Renowned Cancer Theorist Dies

Alfred Knudson, who formulated the “two-hit” theory on the origins of cancer, has passed away at age 93.

Written byAlison F. Takemura
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, NATIONAL CANCER INSTITUTEAlfred Knudson, best known for revealing through mathematics how cancers emerge, died July 10, according to a statement by the Fox Chase Cancer Center in Philadelphia. His wife, Anna Meadows, told the The Washington Post that he had heart ailments and dementia. He was 93.

In 1971, Knudson published an article that unlocked a key question in oncology: How does cancer begin? By analyzing the distribution of children with retinoblastoma—a rare cancer of the eye—with a statistical model, he devised what came to be known as the “two-hit” hypothesis.

The cancer arose when a tumor suppressor gene had undergone two mutations. This explained the two major types of retinoblastoma patients. Some children had inherited one mutation, the first hit, from their healthy parents and, being predisposed, developed multiple tumors in both eyes when radiation of a replication mistake introduced another mutation—the second hit. But other children generally presented a tumor in just one eye at an older age. These patients would have initially carried no mutation, making the chances of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies